GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
On-demand video webcast now available here LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI)...
Pharmaceutical
Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders...
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
The company received a certificate of Good Manufacturing Practice (GMP) compliance following an inspection of their Montreal facility by the...
NEC Orchestrating Future Fund Announces Strategic Investment in Aetion
NEC and Aetion are exploring a collaboration to commercialize global access to real-world data from Japanese electronic health records for...
Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing
Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced...
Health Union Launches Online Community for Opioid Use Disorder
PHILADELPHIA, Feb. 18, 2025 /PRNewswire/ -- Health Union, the leading digital health company for online community-based activation and data, has launched...
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
GC376, the Primary Component of Anivive’s Feline Infectious Peritonitis Drug, Nominated by AVMA and FelineVMA to FDA’s List of Bulk Drug Substance for Compounding Office Stock
Nomination could expedite GC376 availability for veterinariansBlack market FIP treatments shown to be unpredictable and dangerousOther organizations are encouraged to...
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
Commercial success of VINIA validates the power of BioHarvest's patented Botanical Synthesis technology to produce valuable plant-based Compounds at industrial...
Foxx Life Sciences Successfully Hosted an Open House Event in Hyderabad
HYDERABAD, India, Feb. 17, 2025 /PRNewswire/ -- Foxx Life Sciences is delighted to announce the successful completion of its Open...
Welbloom Bio-Tech to Showcase Exclusive Innovations at NPEW 2025: Ergothioneine and Anti-Aging Formulas Take Center Stage
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- Ergothioneine, known for their exceptional nutritional value, have been gaining significant global attention as...
Datalogic showcases comprehensive healthcare solutions at HIMSS 2025
BOLOGNA, Italy, Feb. 17, 2025 /PRNewswire/ -- Datalogic, a global leader in automatic data capture and industrial automation, will unveil...
Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation
SHANGHAI, Feb. 17, 2025 /PRNewswire/ -- Nowadays, artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare...
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has made medical history by...
Ensho Therapeutics Announces Upcoming Presentation at ECCO 2025 of Phase 1, Once-Daily Dosing Data for NSHO-101, an Oral α4β7 Inhibitor for Inflammatory Bowel Disease
MORRIS PLAINS, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on...
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- February 14, 2025 – IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing...
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®
SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call...
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets, Strengthening Collaboration with Distribution Partner McKesson Introducing 'Countmate':...
FLEX MARKETING Launches to Redefine the Healthcare Agency Model
SAN FRANCISCO, Feb. 13, 2025 /PRNewswire/ -- FLEX MARKETING, a dynamic new independent agency built to modernize the approach to...